Litchi chinensis Sonnの多糖質の構造的特徴と低血糖活性について (リッチ) 骨
Yucui Lu1, Xianmei Lnong2, Yuanhui Mao2
1College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China.
Food chemistry
|August 21, 2025
まとめ
炭水化物の消化に関与する重要な酵素を効果的に阻害し,糖尿病管理のための天然の低血糖剤としての可能性を示唆しています.
科学分野:
- 食品科学
- 生物化学
- 栄養薬
背景:
- リッチ (リッチ・チネンシス・ソーン) ペリカルプは生物活性ポリサッカライドの豊富な源です.
- これらのポリサッカリドの構造と生物活性との関係は,まだ十分に研究されていない.
- リッチー・ペリカルプを活用することで 持続可能な機能的な食品の成分を提供できます
研究 の 目的:
- リッチ・ペリカルプから均質なポリサッカリド (LPPs-1) を分離し,特徴づけること.
- LPPs-1の構造を明らかにし,そのモノサッカリド組成とグリコシド結合を明らかにする.
- 炭水化物を消化する酵素に対するLPPs-1の酵素抑制能力を評価する.
主な方法:
- リッチ・ペリカルプからポリサッカリドの分離と浄化.
- 質量平均分子量と多分散性指数による特徴化
- モノサッカライド組成分析と核磁気共振 (NMR) スペクトロスコーピーは,構造の解明のために使用されます.
- α-アミラーゼとα-グルコシダゼに対するインビトロ酵素阻害測定
主要な成果:
- 38. 97 kDaの分子量を持つ均質なポリサッカリドLPPs-1を成功裏に分離した.
- LPPs-1は,アラビノース,ギャラクトゥロン酸,ギャラクトースを主要成分として,9種類の単糖で構成されています.
- NMR分析では,ポリサッカリドの骨格における特定のグリコシド結合が明らかになった.
- LPPs- 1は,α- アミラーゼ (IC50 = 0. 16 mg/ ml) とα- グルコシダゼ (IC50 = 0. 24 mg/ ml) の強力で可逆的な阻害を示した.
結論:
- LPPs-1はリッチ・ペリカルプから派生したユニークな構造を持っています.
- α-アミラーゼとα-グルコシダゼの二重抑制は,低血糖剤としてのLPPs- 1の可能性を強調しています.
- リッチー・ペリカルプのポリサッカリドは 糖尿病の管理に役立つ機能的な食品成分として有望である.
さらに関連する動画
10:46Comprehensive Compositional Analysis of Plant Cell Walls Lignocellulosic biomass Part II: Carbohydrates
Published on: March 12, 2010
30.5K
07:42Author Spotlight: Development and Characterization of Eco-Friendly Lignin-Based Microparticles for Enhanced Delivery of Bioflavonoids
Published on: March 1, 2024
862
関連する概念動画
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
256
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
256
Chemistry of Carbohydrates
75.3K
Carbohydrates are an essential part of the diet in humans and animals. Grains, fruits, and vegetables are natural sources of carbohydrates that provide energy to the body, particularly through glucose, a simple sugar that is a component of starch and an ingredient in many staple foods. The stoichiometric formula (CH2O)n, where n is the number of carbons in the molecule represents carbohydrates. In other words, the ratio of carbon to hydrogen to oxygen is 1:2:1 in carbohydrate molecules. This...
75.3K
Cellulose and Pectic Polysaccharides
3.9K
Every plant cell has a cell wall that protects the cell, provides structural support, and gives the cell shape. Cellulose, the main structural component of the plant cell wall, makes up over 30% of plant matter. It is the most abundant organic compound on earth. Cellulose is an unbranched polysaccharide composed of linear chains of glucose molecules linked by β (1→4) glycosidic bonds.
As a cell matures, its cell wall specializes according to its type. For example, the...
As a cell matures, its cell wall specializes according to its type. For example, the...
3.9K
Biosynthesis of Polysaccharides
90
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
90
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416
Dipeptidyl Peptidase 4 Inhibitors
256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256
